ArticleTransboundary and emerging diseases2026
RNA G-Quadruplexes in the Porcine Deltacoronavirus Genome: Structural Regulation and Therapeutic Targeting for Antiviral Strategies.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- RNA G-Quadruplexes in the Porcine Deltacoronavirus Genome: Structural Regulation and Therapeutic Targeting for Antiviral Strategies.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Porcine deltacoronavirus (PDCoV) is an emerging enteric coronavirus that poses a considerable risk to swine production worldwide. G-quadruplexes (G4s) are noncanonical nucleic acid secondary structures known to regulate critical steps of viral life cycles in multiple viruses; however, the existence and biological role of RNA G4s (RG4s) in PDCoV remain unclear. In this study, we identified putative G4-forming sequences (PQSs) in the nonstructural proteins 2 (Nsp2) and M genes of the PDCoV genome, which are highly conserved across PDCoV strains, based on bioinformatic analysis. Fluorescence turn-on assays and circular dichroism (CD) spectroscopy revealed that these PQSs fold into typical parallel RG4 structures in vitro, and their RG4 formation in living cells was further confirmed using G4-specific probes. Notably, treatment with the G4 ligands TMPyP4 and pyridostatin (PDS) significantly reduced PDCoV N mRNA abundance and corresponding protein expression, concomitant with a marked decrease in viral titers in LLC-PK1 cells. In addition, RG4 structures identified in the Nsp2 and M mRNAs were shown to inhibit translation through a posttranscriptional mechanism. Moreover, G4 ligands, such as PDS and TMPyP4, targeted the RG4 structure in Nsp2 mRNA and significantly inhibited Nsp2-EGFP fusion protein expression without affecting the expression of the M-EGFP fusion protein. In summary, our work supports the presence of sequence-conserved functional RG4 structures in the PDCoV genome and provides new insights into the development of antiviral strategies targeting PDCoV RG4s.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.